Celecoxib also promotes death of neuroblastoma cells synergistically in combination with cytotoxic drugs in vitro and in vivo[10], therefore it is important to determine if PPARδ signalling is a common mechanism of drug resistance in cancer. The gene discussed is PPARD; the disease is neuroblastoma.